Skip to Content
Contact Form Map & Directions Videos

March Madness for Fosamax Filings

03/19/2012
Announcement
BY

March has been a busy month for new filings in the national litigation efforts involving bisphosphonate drug-induced femur fractures.  Currently, there are coordinated state court proceedings pending in Atlantic City, New Jersey as well as Southern California involving the manufacturers of Fosamax, Boniva, and other osteoporosis drugs.  There are also […]

Read More

Actos Litigation Over Bladder Cancer

03/7/2012
Actos
BY

A recently unsealed complaint filed by whistleblower Helen Ge reveals that over four years, Takeda Pharmaceuticals failed to report to the FDA congestive heart failure cases in patients taking Actos. Takeda manufactures the Type II diabetes drug Actos. Actos is the third in a long line of failed Type II […]

Read More

Nuvaring and Increased Risk of Blood Clots

02/15/2012
Articles
BY

Women who are trying to make decisions about a safe and effective form of birth control are having a hard time these days. On the heels of reports that Yaz, Bayer’s number one selling oral birth control pill was linked to abnormally high incidence of blood clotting disorders, it is […]

Read More

Are Treatments for Osteoporosis Sometimes Worse Than the Disease?

02/14/2012
Articles
BY

Bisphosphonates are widely prescribed medications for the treatment and/or prevention of osteoporosis.  The first bisphosphonate (Fosamax, also known as alendronate) for the prevention and/or treatment of osteoporosis was approved for the U.S. market in 1995.  Since that time, four bisphosphonate molecular entities (alendronate sodium, risedronate sodium, ibandronate sodium, and zoledronic […]

Read More

Hear What Our Clients Have To Say

"Cannot say enough about Mr. Ward and his team. Joanna and Mr. Ward helped me through a very difficult time while being extremely professional and prompt. I would highly recommend."
Posted By: Samantha Saundry